Hepatitis C is a viral infection that threatens the health of your liver. Serious complications can arise from untreated hepatitis C, such as liver failure and liver cancer. However, early treatment can help prevent these complications.
There was a time when there was no cure for hepatitis C, however advancements in treatment have made the condition a curable disease. The latest breakthroughs in the treatment of hepatitis C involve the use of highly effective antiviral medications.
In this article, we talk about the goals for hepatitis C treatment, the most advanced treatments, and where you can go for hepatitis C treatment in Austin, Texas.
What is the Goal of Hepatitis C Treatment?
Some of the goals for Hepatitis C are the following:
1. Eliminating the Hepatitis C Virus
The main objective is to clear the hepatitis C virus from the bloodstream, achieving sustained virologic response (SVR). This means that after completing treatment, the virus is no longer detectable in the body. SVR is a measure of successful treatment and indicates a cure for hepatitis C.
2. Slowing Down Liver Inflammation and Scarring
Hepatitis C can cause inflammation in the liver, which can lead to the development of fibrosis (scarring) over time. By effectively treating the infection, antiviral medications can help slow down the progression of liver inflammation and reduce the risk of further scarring.
3. Reducing the Risk of Complications
Successful treatment of hepatitis C can significantly reduce the chances of developing cirrhosis (severe liver scarring) and liver cancer. By eliminating the virus and managing liver inflammation, the risk of long-term complications associated with hepatitis C is minimized.
What Are the Latest Treatments for Hepatitis C?
Sofosbuvir and daclatasvir are antiviral medications used in the treatment of hepatitis C, specifically as part of direct-acting antiviral (DAA) regimens. These drugs have been developed to target and inhibit the replication of the hepatitis C virus in the body, leading to a cure.
Some of the new drugs are:
Mavyret (glecaprevir and pibrentasvir)
- Mavyret is approved by the FDA for the treatment of chronic hepatitis C virus (HCV) infection.
- It is indicated for use in patients 3 years of age and older.
- Mavyret is effective against HCV genotypes 1, 2, 3, 4, 5, or 6, and it can be used in individuals without cirrhosis or with compensated cirrhosis (Child-Pugh A).
- It is also approved for patients with HCV genotype 1 infection who have previously been treated with an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.
Vosevi (sofosbuvir, velpatasvir, and voxilaprevir)
- Vosevi is FDA-approved for the treatment of chronic hepatitis C in adults.
- It is used as a re-treatment option in patients who have been previously treated with an NS5A inhibitor-containing regimen (genotypes 1-6) or a regimen containing sofosbuvir without an NS5A inhibitor (genotypes 1a or 3).
Epclusa (sofosbuvir and velpatasvir)
- Epclusa is approved by the FDA for use in adults and children 3 years of age and older.
- It is indicated for the treatment of HCV genotypes 1, 2, 3, 4, 5, or 6 in patients without cirrhosis or with compensated cirrhosis (Child-Pugh A).
- Epclusa is also approved for use in adults and children 3 years of age and older for the treatment of HCV genotypes 1, 2, 3, 4, 5, or 6 in patients with decompensated cirrhosis when used in combination with ribavirin.
Personalized Treatment Approaches
In addition to the development of new antiviral medications, personalized treatment approaches are also emphasized in the management of hepatitis C:
- Genetic testing now allows doctors to determine a patient’s specific genotype, enabling them to tailor the treatment regimen accordingly.
- Lifestyle changes such as avoiding alcohol and losing weight can help prevent complications from hepatitis C.
A personalized approach only raises the chances of a successful outcome from hepatitis C treatment.
Increased Success Rates and Shorter Treatment Durations
One of the most significant advancements in recent years is the increased success rates and shorter treatment durations for hepatitis C. The new antiviral medications have shown remarkable efficacy, with cure rates exceeding 95% in prescribed patient populations. This high success rate offers hope to individuals who were previously faced with chronic infection and its associated health risks.
Traditionally, hepatitis C treatment could last up to a year and involve weekly injections and multiple pills. However, with the effectiveness of new medications, many patients can now clear the virus in as little as 8 to 12 weeks.
With the latest hepatitis C treatments combined with a personalized approach, you can be cured from the disease and live a healthy life.
Hepatitis C Treatment in Austin, TX
The board-certified gastroenterologists at Austin Gastroenterology are highly experienced in the treatment of liver diseases such as hepatitis C. We offer comprehensive care and the latest treatments for the right patient.
Find out what our GI doctors will recommend as a treatment for your liver condition. To schedule an appointment, call our GI clinic nearest you or use our online request form. Our friendly staff is more than happy to serve you.
